The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial
Taylor, P. R. A., White, J. M., Prescott, R. J., Angus, B., Galloway, M. J., Jackson, G. H., Lessells, A. M., Lucraft, H. H., Summerfield, G. P., Proctor, S. J., On Behalf Of The Scotland and Newca,Volume:
47
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428190600881256
Date:
January, 2006
File:
PDF, 662 KB
english, 2006